baber/WOPTO huggingface dataset:
Patent AU-2007250551-B2 (AU)
Title: A pant-type absorbent article and a method for producing pant-type absorbent articles.
Inventor: WASTLUND-KARLSSON JAN
IPC: A61F13/496
Filed: 2007-05-11
Granted: 2012-09-06
Abstract: The invention concerns a method for producing pant-type absorbent articles each article (21) including a chassis structure having at least one elastic panel and an integrated absorbent core component (32), the method including a continuous pant-forming process comprising forming the chassis structure and incorporating the absorbent core component (32) into the chassis structure. The at least one elastic panel is formed by a) separately producing a two-layer laminate (8) comprising a first non-elastic fibrous nonwoven web (1) and an elastic film (6), b) activating the two-layer laminate (8) by incremental stretching in at least one direction to render the two-layer laminate (8) elastically stretchable, c) stretching the activated two-layer laminate (8) by 35-200% in at least one direction, d) introducing the two-layer laminate (24,25) in the pant-forming process, and e) laminating the elastic film (6) of the stretched two-layer laminate (24,25) to an elastic or nonwoven chassis component (39,40, 23, 54). The invention also relates to an absorbent pant-type article produced in accordance with the method.
Patent AU-2007258949-B2 (AU)
Title: Process for the preparation of S-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates
Inventor: WAKCHURE V
IPC: A61P5/44
Filed: 2007-06-11
Granted: 2013-02-21
Abstract: The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of steroidal 17β-carboxylic thioates, such as fluticasone propionate formula (I), using soluble mixed fluorides to introduce fluorine by displacing an appropriate leaving group X in compounds formula (II) resulting in selective and controlled fluorination. The present invention also relates to intermediates formula (II) and their preparation.
Patent AU-2007338942-B2 (AU)
Title: A system and method for adjustment of a milking location
Inventor: HALLSTROM ANDERS
IPC: A01K1/12
Filed: 2007-12-21
Granted: 2012-06-28
Abstract: The present invention relates to a system (10) for automatic adjustment of at least one interior dimension of a milking location (12) for an animal. The milking location (12) comprises an enclosure formed by e.g. four confining means (12,..,, 12), whereby at least one of the confining means (12,..., 12) is movable. The system (10) comprises a first sensor means (14) operable to detect the presence of an animal In the milking location (12). The system (10) also comprises a control means (18) connected to the first sensor means (14), When an animal is detected in the milking location (12), the control means (18) is operable to move the at least one movable confining means (12,..,, 12) stepwise, in order to adjust the at least one interior dimension of the milking location (12) to the animal.
Patent AU-2007342305-B2 (AU)
Title: Food products comprising a slowly digestible or digestion resistant carbohydrate composition
Inventor: RAM SANTHANAGOPALAN
IPC: A23L27/00
Filed: 2007-01-24
Granted: 2011-11-24
Abstract: A food product comprises an oligosaccharide composition that is digestion resistant or slowly digestible. The oligosaccharide composition can be produced by a process that comprises producing an aqueous composition that comprises at least one oligosaccharide and at least one monosaccharide by saccharification of starch, membrane filtering the aqueous composition to form a monosaccharide-rich stream and an oligosaccharide-rich stream, and recovering the oligosaccharide-rich stream. Alternatively, the oligosaccharide composition can be produced by a process that comprises heating an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and that has a solids concentration of at least about 70% by weight, to a temperature of at least about 4O0C, and contacting the feed composition with at least one catalyst that accelerates the rate of cleavage or formation of glucosyl bonds for a time sufficient to cause formation of non-linear saccharide oligomers, wherein a product composition is produced that contains a higher concentration of non-linear saccharide oligomers than linear saccharide oligomers.
Patent AU-2007343701-B2 (AU)
Title: Method and apparatus for gender selection based on pH
Inventor: PRIEN SAMUEL D
IPC: C12N5/02
Filed: 2007-10-31
Granted: 2013-01-31
Abstract: The present invention includes methods and apparatus to separate X or Y-chromosome bearing sperm cells in a population by first placing the population of sperm cells at physiological pH environment, and simultaneously contacting the population of sperm cells with one or more additional sub-environments with different pH values. The exposure allows mobile sperm cells bearing X or Y-chromosome to migrate to the different pH sub-environments, wherein each cell only exposed or come in contact with one pH sub-environment. Finally, the collecting X or Y- chromosome enriched population of sperm cells is performed.
Patent AU-2008218806-B2 (AU)
Title: Imidazoquinolines as dual lipid kinase and mTOR inhibitors
Inventor: PETER FINAN
IPC: A61P35/00
Filed: 2008-02-19
Granted: 2011-12-01
Abstract: The invention relates to the use of compounds of formula: (I) in the treatment of mammalian target of rapamycin (mTOR) kinase dependent diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases.
Patent AU-2008249143-B2 (AU)
Title: Partial and full agonists of A1 adenosine receptors
Inventor: KEVIN SHENK
IPC: A61P9/08
Filed: 2008-11-21
Granted: 2011-08-25
Abstract: Disclosed are novel compounds that are partial and full A, adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, myocardial infarction and hyperlipidemia.
Patent AU-2008252014-B2 (AU)
Title: Protein assay
Inventor: DE ANGLIS ASHLEY
IPC: A61K38/00
Filed: 2008-05-22
Granted: 2014-06-05
Abstract: ETH5403WOPCT A method is described for the measurement of thrombin activity in the presence of fibrinogen, or for the measurement of the functionality of fibrinogen in the presence of thrombin.
Patent AU-2008258282-B2 (AU)
Title: Apparatus for determining the award of a plurality of sets of prizes
Inventor: COWAN STEPHEN
IPC: A63F13/12
Filed: 2008-06-06
Granted: 2012-04-26
Abstract: There is described an apparatus for determining the award of a plurality of sets of prizes where each prize in each set has a respective prize value. The apparatus includes memory for storing data indicative of the prize values and an input device being responsive to input signals from a respective plurality of gaming terminals for providing an increment signal. An increment device is included for accessing the data to define a current prize value as one of the prize values from one of the sets; and being responsive to the increment signal for incrementing an accumulated value toward the current prize value. Also included is a comparator responsive to the current prize value and the accumulated value for determining if the current prize value is to be awarded and, if so, generating an award signal and removing from the one of the sets the prize value corresponding to the current prize value. A controller is responsive to the award signal for determining if the one of the sets includes at least one remaining prize value and, if so, actuating the increment device to define the current prize value as one of the at least one remaining prize value. If not, actuating the increment device to define the current prize value as one of the prize values from another one of the sets.
Patent AU-2008268262-B2 (AU)
Title: MetAP-2 inhibitor polymersomes for therapeutic administration
Inventor: BENNY-RATSABY OFRA
IPC: A61K47/48
Filed: 2008-06-26
Granted: 2014-11-13
Abstract: Described herein are MetAP-2 inhibitors and compositions and formulations thereof, and more particularly compositions and formulations of MetAP-2 inhibitors wherein the MetAP-2 inhibitor is associated with a block copolymer comprising a hydrophilic polymer moiety and a hydrophobic polymer moiety. The present invention also relates to compositions and formulations comprising MetAP-2 inhibitors for oral administration or administration via routes such as topical or ocular administration. The present invention also provides methods to treat conditions associated with or related to the over-expression or over-activity of MetAP-2 by administering the compositions and formulations comprising MetAP-2 inhibitors as disclosed herein.
Patent AU-2008332278-B2 (AU)
Title: Cancer vaccine composition
Inventor: SUGIYAMA HARUO
IPC: A61P35/02
Filed: 2008-12-05
Granted: 2013-06-13
Abstract: Disclosed is a cancer vaccine composition for a human leukocyte antigen (HLA)-A
Patent AU-2008352050-B2 (AU)
Title: Tensionable spiral bolt with resin nut and related method
Inventor: FOX WILLIAM G
IPC: E21D21/00
Filed: 2008-03-05
Granted: 2015-07-02
Abstract: In one aspect of the invention, an apparatus and related methods for installation in a borehole formed in a face of a mine passage comprises an elongated bolt including a spiral shaft portion for positioning in the borehole. A hardened, stationary resin nut formed in only part of the borehole, preferably spaced from the distal end thereof, receives the spiral shaft portion of the bolt. Consequently, rotation of the spiral shaft portion within the hardened resin nut serves to move the bolt within the borehole, such as for purposes of tensioning.
Patent AU-2009202626-B2 (AU)
Title: Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
Inventor: WYSS JOSEPH G
IPC: A61F2/38
Filed: 2009-06-29
Granted: 2015-07-09
Abstract: -50 An orthopaedic knee prosthesis includes a tibial bearing and a femoral component configured to articulate with the tibial bearing. The femoral component includes a posterior cam configured to contact a spine of the tibial bearing and a 5 condyle surface curved in the sagittal plane. The radius of curvature of the condyle surface decreases gradually between early-flexion and mid-flexion. Additionally, in some embodiments, the radius of curvature of the condyle surface may be increased during mid-flexion. 29/06/09,va 18080 speci,50
Patent AU-2009213045-B2 (AU)
Title: Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
Inventor: CHARNEAU PIERRE
IPC: A61P31/12
Filed: 2009-09-10
Granted: 2012-12-20
Abstract: An HIV-1 type (or subtype) 0 retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognised by antibodies isolated from a serum resulting from infection by an HIV-1 type 0 VAU strain or an HIV-1 type (or subtype) 0 DUR strain.
Patent AU-2009217376-B2 (AU)
Title: Threaded rod and dosing device for an injection device
Inventor: MOSER ULRICH
IPC: A61M5/24
Filed: 2009-09-17
Granted: 2013-01-17
Abstract: The invention relates to a threaded rod (4) for an injection device (1). which comprises a thread (4b, 4c, 4d) which is arranged on the external side of the threaded rod (4). The thread (4b, 4c, 4d) supports, at least partially, engaging elements and/or a toothing (4b). The invention also relates to a dosing device for an injection device (1). comprising a rotational defining element which enables the threaded rod to be rotated in one direction and blocked in the counter direction, by means of at least one blocking element (6f) and/or one toothing (lj, 3j). which co-operates with a thread comprising a toothing (4b) of the threaded rod (4) and/or engaging elements (4c) off the threaded rod (4). The invention further relates to an injection device which comprises at least one engaging element (60 and/or one toothing or stop (lj, 3j) which co-operate with the toothing on the thread (4b) of a threaded rod (4) or with a blocking element (4c) of the threaded rod (4), in order to rotate the threaded rod (4) in one direction in relation to the injection device (1) and to block in the counter direction. I I v 3c ib 6a . . 4b 6b
Patent AU-2009226379-B2 (AU)
Title: Hydrogen generator, ammonia combustion internal combustion engine, and fuel cell
Inventor: NAKANISHI HARUYUKI
IPC: C01B3/04
Filed: 2009-03-18
Granted: 2012-02-23
Abstract: Disclosed is a hydrogen generator that can be operated in a broad temperature range. The hydrogen generator comprises a first ammonia converting part (10) having a hydrogen producing material that is reacted with ammonia in a first temperature range to produce hydrogen, a second ammonia converting part (20) having an ammonolysis catalyst that decomposes ammonia into hydrogen and nitrogen in a second temperature range, an ammonia supply part (30) for supplying ammonia, and an ammonia supply passage (31) for supplying ammonia from the ammonia supply part into the first and second ammonia converting parts. The first temperature range includes a temperature below the second temperature range. Hydrogen is produced from ammonia by performing switching between the first ammonia converting part and the second ammonia converting part. Also disclosed are an ammonia combustion internal combustion engine and a fuel cell comprising the hydrogen generator.
Patent AU-2009240650-B2 (AU)
Title: Null pilots for interference estimation in a wireless communication network
Inventor: AGRAWAL AVNEESH
IPC: H04W72/08
Filed: 2009-04-22
Granted: 2013-03-21
Abstract: Techniques for transmitting null pilots to support interference estimation in a wireless network are described. A null pilot is non-transmission on designated time-frequency resources by a cell or a cluster of cells supporting cooperative transmission to a UE. The received power of the null pilot from the cell or cluster of cells may be indicative of interference from other cells. In one design, a cell in the cluster may determine resources for sending a null pilot by the cell. The cell may transmit the null pilot (i.e., send no transmissions) on the resources to allow UEs to estimate out-of-cluster interference. Some or all cells in the cluster may transmit null pilots on the same resources. The cell may receive interference and channel information from the UE and may send data transmission to the UE based on the interference and/or channel information. Remaining cells in the cluster may reduce interference to the UE.
Patent AU-2009243428-B2 (AU)
Title: Exposing Process Flows and Choreography Controllers as Web Services
Inventor: SAPURAM RAGHUNATH
IPC: G06Q10/10
Filed: 2009-11-30
Granted: 2012-05-17
Abstract: C:NRPortbnDCC4DER\2604516_1.DOC-30/I l2009 A method of choreographing web services, wherein a choreography includes a plurality of messages mapped to standard-compliant interfaces of a plurality of service 5 entities, assigning a conversation identifier to the messages, and conducting messages exchanges among the service entities according to the choreography, the method including: routing the message exchanges through a choreography agent, wherein the choreography agent: inspects messages to fund data fields that imply which choreography 10 instance the messages belong to; updates the status of a choreography instance implied by the inspection of the messages, and forwards the messages to their destinations.
Patent AU-2009248815-B2 (AU)
Title: Cable transport system
Inventor: TILLEY MARTIN C
IPC: B61B1/00
Filed: 2009-05-26
Granted: 2014-04-10
Abstract: A method and system of devices facilitate the uninterrupted transport of a payload of persons (110) or cargo along a multi-segmented guide cable (180), or zip line, suspended from a series of support structures (120). Transfer mechanisms (800, 810) allow the cable to loop to a starting location or to transport between discrete endpoints. A trolley (200) carrying the payload may be powered by gravity alone, or a motorized assist may allow the cable course to be traversed without regard to relative elevations of cable supports. Safety mechanisms (300) prevent the trolley from leaving the cable (180) unintentionally. The system enables one or more riders (110) to travel along the guide cable (180) at velocities desired for recreational purposes while assuming many body positions, such as prone, sitting or standing, to provide the sensation of flying like a bird.
Patent AU-2009266833-B2 (AU)
Title: Melt granulation process
Inventor: LI SHOUFENG
IPC: A61K9/16
Filed: 2009-07-02
Granted: 2013-01-31
Abstract: A process for preparing solid dosage forms that contain a quinoline compound. The process, for example, provides for the inventive use of an extruder, especially a twin screw extruder, to melt granulate the quinoline compound with a granulation excipient.
Patent AU-2009320287-B2 (AU)
Title: Virus like particle compositions and methods of use
Inventor: NABEL GARY J
IPC: A61K39/12
Filed: 2009-11-24
Granted: 2015-10-08
Abstract: The invention features compositions and methods for the prevention or treatment of one or more strains of Chikungunya virus, as well as other alphavirus-mediated diseases.
Patent AU-2009342654-B2 (AU)
Title: Morphinan derivatives with high oral bioavailability
Inventor: TURNCLIFF RYAN
IPC: A01N43/42
Filed: 2009-12-04
Granted: 2013-09-05
Abstract: The instant application relates to morphinan derivatives of formula I with enhanced oral bioavailability for the treatment of diseases associated with opioid receptor activity or blockade including alcohol and opiate addiction.
Patent AU-2010200419-B2 (AU)
Title: Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
Inventor: WOLFE DAVID M
IPC: C12Q1/68
Filed: 2010-02-05
Granted: 2012-05-31
Abstract: The present invention relates to a method of detecting the presence or absence of herpes simplex virus (HSV) in a sample based on amplifying a portion of the Glycoprotein G (US4) gene of HSV and detecting the presence of the amplified nucleic acid using primers and detector primers as described herewith. The method of the invention further identifies the type of HSV, either HSV-I or HSV-2, in a sample. Also encompassed by the invention is a kit comprising the primers and detector primers which may be used with the amplification method described herewith. AAAAAGACCC CGACCCGCGT CTGTGGTGTT TTTGGCATCA TGTCGCCGGG 50 CGCCATGCGT GCCGTTGTTC CCATTATCCC ATTCCTTTTG GTTCTTGTCG 100 GTGTATCGGG GGTTCCCACC AACGTCTCCT CCACCACCCA ACCCCAACTC 150 CAGACCACCG GTCGTCCCTC GCATGAAGCC CCCAACATGA CCCAGACCGG 200 CACCACCGAC TCTCCCACCG CCATCAGCCT TACCACGCCC GACCACACAC 250 CCCCCATGCC AAGTATCGGA CTGGAGGAGG AGGA---AGA GGAGGAGGGG 300 GCCGGGGACG GCGAACATCT TGAGGGGGGA GATGGGACCC GTGACACCCT 350 ACCCCAGTCC CCGGGCCCAG CCTTCCCGTT GGCTGAGGAC GTCGAGAAGG 400 ACAAACCCAA CCGTCCCGTA GTCCCATCCC CCGATCCCAA CAACTCCCCC 450 GCGCGCCCCG AGACCAGTCG CCCGAAGACA CCCCCCACCA TTATCGGGCC 500 GCTGGCAACT CGCCCCACGA CCCGACTCAC CTCAAAGGGA CGACCCTTGG 550 TTCCGACGCC TCAACATACC CCGCTGTTCT CGTTCCTCAC TGCCTCCCCC 600 GCCCTGGACA CCCTCTTCGT CGTCAGCACC GTCATCCACA CCTTATCGTT 650 TTTGTGTATT GGTGCGATGG CGACACACCT GTGTGGCGGT TGGTCCAGAC 700 GCGGGCGACG CACACACCCT AGCGTGCGTT ACGTGTGCCT GCCGTCCGAA 750
Patent AU-2010216510-B2 (AU)
Title: Ophthalmic lens with optical sectors
Inventor: WANDERS BERNARDUS FRANCISCUS MARIA
IPC: G02C7/04
Filed: 2010-02-17
Granted: 2015-05-07
Abstract: The invention relates to an ophthalmic lens comprising a main lens part, a recessed part, an optical centre, and an optical axis through said optical centre, said main lens part having at least one boundary with said recessed part, said main lens part having an optical power of between about -20 to about +35 dioptre, said recessed part positioned at a distance of less than 2 mm from said optical centre and comprising a near part having a relative dioptre of about +1.0 to about +5.0 with respect to the optical power of said main lens part, said boundary or boundaries of said recessed lens part with said main lens part form a blending part or blending parts, are shaped to refract light away from said optical axis, and have a curvature resulting in a loss of light, within a circle with a diameter of 4 mm around said optical centre, of less than about 15%.
Patent AU-2010217289-B2 (AU)
Title: A hard-metal body
Inventor: KONYASHIN IGOR YURI
IPC: B22F7/00
Filed: 2010-03-01
Granted: 2015-11-05
Abstract: The invention relates to hard-metal body comprising a hard-metal, the hard-metal comprising tungsten carbide grains and metal binder comprising cobalt having a concentration of tungsten dissolved therein, the body comprising a surface region adjacent a surface and a core region remote from the surface, the surface region and the core region being contiguous with each other; the mean binder fraction of the core region being greater than that of the surface region; the mean carbon concentration within the binder being higher in the surface region than in the core region; to tools comprising same and methods of making same.
Patent AU-2010233147-B2 (AU)
Title: Use of tetrahydrobiopterin as a marker and a therapeutic agent for Fabry disease
Inventor: SCHIFFMANN RAPHAEL
IPC: A61P3/00
Filed: 2010-04-09
Granted: 2012-10-25
Abstract: Blood and tissue markers of the metabolic status, risk of health complications in Fabry disease patients and as a biomarker to follow the efficacy of treatment in animal models and patients with Fabry disease comprising tetrahydrobiopterin (BH4), precursors and metabolites of BH4, and other related co-factors is disclosed herein. The present invention further describes the use of BH4 therapy as a treatment option for Fabry disease to prevent, slow or reverses vascular cardiac and renal manifestations of Fabry disease.
Patent AU-2010235931-B2 (AU)
Title: Table game system
Inventor: SHIGETA YASUSHI
IPC: A63F1/12
Filed: 2010-10-21
Granted: 2012-08-02
Abstract: A table game system including cards on which code elements are arrayed as an ultraviolet-ray reaction code representing the number of a card and a card shooter apparatus that is put on a game table and has a card reading function that reads the number of the card- The card shooter apparatus includes a card guide unit that guides cards which are pulled out one by one from a card housing onto the game table. The card shooter apparatus further includes black light sensors that read the ultraviolet-ray reaction code representing the number of the card from the card guided by the card guide unit. The apparatus also includes first and second card detecting sensors that are arranged along a guiding direction of the card guide unit to detect the existence or non-existence of a card. The apparatus also includes a measurement validity/invalidity determining means that determines whether or not a card has normally passed along the card guide unit, on the basis of detection signals of the first and second card detecting means. The black light sensors are adapted to detect the code elements which are arrayed in a card pulling direction as an ultraviolet-ray reaction code and to output a detection signal. The card shooter apparatus further includes a number specifying means that specifies the number of a card associated with the ultraviolet-ray reaction code on the basis of the detection signals of the black light sensors, a win/lose determining means that determines the win or lose of a card game on the basis of the numbers of the cards that are sequentially read by the black light sensors and an output means that outputs a game result determined by the win/lose determining means. a-) c-c 4'of co Q :J cc cc cc co '